Combination therapy with PXS-5505 delays tumor progression and improves survival in murine CCA models. Thus, chemotherapy combined with PXS-5505 represents a novel therapeutic strategy for treating CCA.Paul R BurchardLuis I RuffoloNicholas A Ullman...
Pan-lysyl oxidase inhibition with Pxs-5505 decreases tumor burden and interstitial pressure of murine cholangiocarcinoma - a novel therapeutic strategy for clinical translationdoi:10.1016/j.hpb.2021.06.048P. BurchardL. RuffoloN. UllmanB. Dale